NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund a number of research centers over the next two years with grants supporting translational research projects that focus on cancers of specific organs.

Funded through its Specialized Programs of Research Excellence (SPORE) program, NCI will fund between 16 and 24 awards that will conduct projects focused on improving early detection, diagnosis, prevention, and treatment of these cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.